Results for viral load on Vacc-4x

Oslo 15.02.2012 – With final review of phase IIb viral load data completed, researchers confirm statistically significant reduction of HIV viral load on Vacc-4x compared to placebo  Bionor`s Clinical Research Program Moves Forward with Three Main Pathways to Market News Summary • Final review of phase IIb data confirms statistically significant 64% reduction of viral load …

Read more